Skip to main content
logo
Neuland Laboratories Limited (NSE:NEULANDLAB)
India flag India · Delayed Price · Currency is INR
12,635
+608 (5.06%)
Apr 1, 2026, 3:29 PM IST

Neuland Laboratories Revenue

Neuland Laboratories had revenue of 4.40B INR in the quarter ending December 31, 2025, with 10.47% growth. This brings the company's revenue in the last twelve months to 15.75B, up 2.71% year-over-year. In the fiscal year ending March 31, 2025, Neuland Laboratories had annual revenue of 14.77B, down -5.24%.

Revenue (ttm)
15.75B
Revenue Growth
+2.71%
P/S Ratio
10.27
Revenue / Employee
8.78M
Employees
1,794
Market Cap
161.72B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202514.77B-817.43M-5.24%
Mar 31, 202415.59B3.67B30.81%
Mar 31, 202311.91B2.40B25.20%
Mar 31, 20229.52B147.07M1.57%
Mar 31, 20219.37B1.73B22.64%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Piramal Pharma88.71B
Emcure Pharmaceuticals88.50B
Alembic Pharmaceuticals72.67B
Gland Pharma61.13B
Strides Pharma Science47.26B
NATCO Pharma45.63B
Akums Drugs and Pharmaceuticals42.60B
Wockhardt31.74B
Revenue Rankings

Neuland Laboratories News

More News